INS and type 2 diabetes mellitus: Although studies of ABHD1 in diabetes and its complications are rare, research has found that inhibitors of ABHD6 in the same family may play a role in the treatment of type 2 diabetes, insulin resistance, and metabolic syndrome by promoting insulin secretion [34].